[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 21,413.4 Million by 2033 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
10. Dezember 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Gastrointestinal Endoscopy Devices Market Size, Trends and Insights By Product...
Lucinity and Facctum Partner for AI-Powered, Real-Time Watchlist Screening and Investigations
08. Oktober 2024 07:43 ET
|
Lucinity
Lucinity and Facctum Partner for AI-Powered, Real-Time Watchlist Screening and Investigations
The Southport CoLAB Community Lecture Series to Host Fairfield County’s Sneak Peek Screening and Panel Discussion for ‘Hopeville: How to Win the Reading Wars’
28. März 2024 10:45 ET
|
The Southport School Inc
SOUTHPORT, Conn., March 28, 2024 (GLOBE NEWSWIRE) -- The Southport CoLAB, a resource providing quality education training for professionals, educators, and families to affect positive outcomes for...
High Throughput Screening Market Set to Exceed US$ 92.5 Billion by 2034, Riding on 10.5% CAGR | Reveals FMI Inc.
07. März 2024 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 07, 2024 (GLOBE NEWSWIRE) -- The global high throughput screening market had an estimated valuation of US$ 25.7 billion in 2023 and is expected to reach a size of US$ 92.5 billion...
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
18. September 2023 05:59 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
28. August 2023 06:35 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
Voyce From One Health Group Wins “Overall Healthcare Product Of The Year” In 2023 Pet Innovation Awards
17. August 2023 08:00 ET
|
Pet Innovation Awards
LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
28. Juli 2023 13:24 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), this week was granted a patent for its Patient Home Monitoring...
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
26. Juni 2023 06:15 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
Inventiva and Echosens launch joint initiative to increase NASH awareness and access to screening for at-risk patients
08. Juni 2023 02:30 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States) / Paris (France) and Waltham (United States), June 8, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage...